Dr. Myles Richard Clancy

D.M.D. | Pediatric Dentist



  
  209 Harvard St, Brookline
  Massachusetts, 02446-5071

  617-731-5437    Maps & Directions
Dr. Myles Richard Clancy is a Brookline, Massachusetts based Pediatric Dentist who is specialized in Pediatric Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 209 Harvard St, Brookline. Patients can reach him at 617-731-5437.
Dr. Myles Richard Clancy provides both primary and comprehensive preventive and therapeutic oral health care for infants and children through adolescence, including those with special health care needs.
Complete Profile:
Dr. Myles Richard Clancy speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Myles Richard Clancy
Specialization: Pediatric Dentist
Gender:Male
Credentials: D.M.D.
Accepts Medicare Assignment:May Accept
Practice Address:209 Harvard St, Brookline,
Massachusetts, 02446-5071
Phone:617-731-5437
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9436444072
Enrollment ID: I20160822002990
NPI Number: 1922456276
NPI Enumeration Date: 27 May, 2016
NPI Last Update On: 12 Sep, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 801 S Paulina St, M/c 850, Rm 256
Chicago, Illinois
Zip: 60612-7210
Patients can reach Dr. Myles Richard Clancy at 209 Harvard St, Brookline, Massachusetts or can call to book an appointment on 617-731-5437. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.

Comments/ Reviews: